Core Scientific, Inc.'s stock soared 6.43% during intraday trading on Tuesday, reflecting strong upward momentum in the session.
The surge was driven by investment bank B.Riley raising its target price for the company from $30 to $33 while maintaining a buy rating. Additionally, recent filings of Form 4 and Schedule 13G/A documents indicate ongoing changes in institutional investor holdings, which the market interprets as positive signals of capital inflows.
Sector linkage support from compute-related names also contributed to the positive sentiment, with IREN Ltd rising 4.44% in the same session, providing additional buoyancy to Core Scientific's advance.
Comments